Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1250 participants
OBSERVATIONAL
2001-07-01
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia
NCT00005313
Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals
NCT00365235
Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS
NCT00005345
Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders
NCT01571609
HYPGENE-Genetics Fitness Obesity & Risk of Hypertension
NCT00083811
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mexican American (parents and at least 3/4 four grandparents
* age \>18 years
* GDM in singleton pregnancy in prior 5 years
* impaired glucose levels or sum of five OGTT glucose values \>625 mg/dl on 75 gram oral glucose tolerance test
* Fasting plasma glucose \<126 mg/dl
* At least two adult siblings of cousin not known to have diabetes and available for phenotyping; .
2. Siblings and Cousins of GDM Probands
* Full sibling or first cousin of GDM proband
* Age \>18 yrs
* Fasting plasma glucose \<126 mg/dl.
3. Parents, Uncles and Aunts of GDM Probands
* Full blooded parent, uncle or aunt of GDM proband
4. Control Proband
* Mexican American as defined for GDM probands
* One glucose challenge test result \<120 mg/dl at \>24 weeks gestation
* No diabetes in first degree relative
* Frequency matched to GDM probands by distributions of age, BMI and parity.
5. Spouse of GDM or Control Proband
* Spouse of GDM proband
* Age \>18
* At least one child with proband able to provide DNA
6. Child of Proband
* Child of GDM or control proband and spouse who provided DNA
Exclusion Criteria
* Chronic medical illness or medication known to alter glucose/insulin metabolism
* Current pregnancy or breastfeeding
* Ilicit drug or alcohol abuse,
* Inability or unwillingness to give informed consent.
2. SIBLINGS AND COUSINS OF PROBANDS:
* Chronic medical illness or medication known to affect glucose/insulin metabolism
* Current pregnancy or breastfeeding,
* Ilicit drug or alcohol abuse
* Inability or unwillingness to give informed consent.
3. PARENTS OF PROBANDS
* Inability or unwillingness to give informed consent.
4. SPOUSE OF GDM or CONTROL PROBAND
* Inability or unwillingness to give informed consent.
5. CHILD OF GDM or CONTROL PROBAND
* Lack of parent consent or child assent.
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaiser Permanente
OTHER
University of Southern California
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Buchanan
Professor of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS 013025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.